| Pharmaceutical active ingredients: |
| Fenoterol HydrobromideIpratropium Bromide |
| Available forms, composition and doses of Arelcant: |
| N / A |
| Arelcant medical category: |
| Human:Antiasthmatic and COPD preparationsAntimuscarinics antispasmodics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R03AK03 - Fenoterol and other drugs for obstructive airway diseases |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Boehringer Ingelheim |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Fensol | Fenoterol Hydrobromide | Sandoz |
| Parsistene | Fenoterol Hydrobromide | Boehringer Ingelheim |
| Partusisten | Fenoterol Hydrobromide | Boehringer Ingelheim; Vifor Pharma |
| Segamol | Fenoterol Hydrobromide | Boehringer Ingelheim |
| Fymnal | Fenoterol Hydrobromide; Ibuprofen | Americano de Farmacoterapia Laboratorio |
| Atrovent Beta | Fenoterol Hydrobromide; Ipratropium Bromide | Boehringer Ingelheim |
| Atrovent Comp | Fenoterol Hydrobromide; Ipratropium Bromide | Boehringer Ingelheim |
| Berodual | Fenoterol Hydrobromide; Ipratropium Bromide | Boehringer Ingelheim; DKSH; Istituto de Angeli; Metro Drug Distribution; Zuellig Pharma |
| Berodual F | Fenoterol Hydrobromide; Ipratropium Bromide | Boehringer Ingelheim; Metro Drug Distribution |
| Berodual Forte | Fenoterol Hydrobromide; Ipratropium Bromide | Boehringer Ingelheim; Zuellig Pharma |